Search research articles
Contact Us
Filters
Showing results (31-40 of 82) with videos related to
Page
of 9
Sort By:
Journal of the National Cancer Institute
|
August 3, 2022
Discoidin Domain Receptor-Driven Gene Signatures as Markers of Patient Response to Anti-PD-L1 Immune Checkpoint Therapy
Sungyong You, Minhyung Kim, Xen Ping Hoi, et al.
Neuro-Oncology
|
April 4, 2017
Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy
Tiffany R Hodges, Martina Ott, Joanne Xiu, et al.
Clinical Lung Cancer
|
October 9, 2024
Use of Oncogene Overlap by Tissue-Based Next-Generation Sequencing to Explore the Mutational Landscape and Survival Impact of HER2, KRAS and MET Copy-Number Gain in Nonsmall Cell Lung Cancer
Alexander S Watson, Harris B Krause, Andrew Elliott, et al.
JTO Clinical and Research Reports
|
September 30, 2021
Identification of Novel <i>CDH1-NRG2</i>α and <i>F11R-NRG2α</i> Fusions in NSCLC Plus Additional Novel <i>NRG2α</i> Fusions in Other Solid Tumors by Whole Transcriptome Sequencing
Sai-Hong Ignatius Ou, Joanne Xiu, Misako Nagasaka, et al.
Medicina (Kaunas, Lithuania)
|
December 23, 2022
<i>BRCA1/2</i> Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase (PARP) Inhibitors or Platinum Agents
Sourat Darabi, David R Braxton, Joanne Xiu, et al.
Scientific Reports
|
March 12, 2021
Pan-cancer analysis of RNA expression of ANGIOTENSIN-I-CONVERTING ENZYME 2 reveals high variability and possible impact on COVID-19 clinical outcomes
Andrew Elliott, Michelle Saul, Jia Zeng, et al.
Head & Neck
|
November 12, 2025
Genomic and Immune Correlates of EZH2 Expression and Activity in Olfactory Neuroblastoma
Elisabetta Xue, Tolulope Adeyelu, Harris Krause, et al.
Neuro-Oncology Advances
|
March 24, 2020
Primary CNS lymphoma commonly expresses immune response biomarkers
Alexander Ou, Ashley Sumrall, Surasak Phuphanich, et al.
Journal of Neuropathology and Experimental Neurology
|
May 3, 2018
Targetable Gene Fusions Associate With the IDH Wild-Type Astrocytic Lineage in Adult Gliomas
Sherise D Ferguson, Shouhao Zhou, Jason T Huse, et al.
Nature Communications
|
March 19, 2025
Real-world evidence provides clinical insights into tissue-agnostic therapeutic approvals
George W Sledge, Takayuki Yoshino, Joanne Xiu, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 82) with videos related to
Sort By:
Page
of 9
Journal of the National Cancer Institute
|
August 3, 2022
Discoidin Domain Receptor-Driven Gene Signatures as Markers of Patient Response to Anti-PD-L1 Immune Checkpoint Therapy
Sungyong You, Minhyung Kim, Xen Ping Hoi, et al.
Neuro-Oncology
|
April 4, 2017
Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy
Tiffany R Hodges, Martina Ott, Joanne Xiu, et al.
Clinical Lung Cancer
|
October 9, 2024
Use of Oncogene Overlap by Tissue-Based Next-Generation Sequencing to Explore the Mutational Landscape and Survival Impact of HER2, KRAS and MET Copy-Number Gain in Nonsmall Cell Lung Cancer
Alexander S Watson, Harris B Krause, Andrew Elliott, et al.
JTO Clinical and Research Reports
|
September 30, 2021
Identification of Novel <i>CDH1-NRG2</i>α and <i>F11R-NRG2α</i> Fusions in NSCLC Plus Additional Novel <i>NRG2α</i> Fusions in Other Solid Tumors by Whole Transcriptome Sequencing
Sai-Hong Ignatius Ou, Joanne Xiu, Misako Nagasaka, et al.
Medicina (Kaunas, Lithuania)
|
December 23, 2022
<i>BRCA1/2</i> Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase (PARP) Inhibitors or Platinum Agents
Sourat Darabi, David R Braxton, Joanne Xiu, et al.
Scientific Reports
|
March 12, 2021
Pan-cancer analysis of RNA expression of ANGIOTENSIN-I-CONVERTING ENZYME 2 reveals high variability and possible impact on COVID-19 clinical outcomes
Andrew Elliott, Michelle Saul, Jia Zeng, et al.
Head & Neck
|
November 12, 2025
Genomic and Immune Correlates of EZH2 Expression and Activity in Olfactory Neuroblastoma
Elisabetta Xue, Tolulope Adeyelu, Harris Krause, et al.
Neuro-Oncology Advances
|
March 24, 2020
Primary CNS lymphoma commonly expresses immune response biomarkers
Alexander Ou, Ashley Sumrall, Surasak Phuphanich, et al.
Journal of Neuropathology and Experimental Neurology
|
May 3, 2018
Targetable Gene Fusions Associate With the IDH Wild-Type Astrocytic Lineage in Adult Gliomas
Sherise D Ferguson, Shouhao Zhou, Jason T Huse, et al.
Nature Communications
|
March 19, 2025
Real-world evidence provides clinical insights into tissue-agnostic therapeutic approvals
George W Sledge, Takayuki Yoshino, Joanne Xiu, et al.
Page
of 9